Michigan’s St. Joseph Mercy Brighton Medical Center Launches Clinical Trials Thanks to New Grant

Aug 29, 2019 | Grants, NCI, NCORP, St Joseph Mercy Health System

Michigan’s St. Joseph Mercy Brighton Medical Center Launches Clinical Trials Thanks to New Grant

St. Joseph Mercy Brighton Medical Center has been awarded a grant for $19.3 million as part of the National Cancer Institute’s Community Oncology Research Program (NCORP), a national network of organizations that offer cancer care to diverse populations in community-based health care practices around the nation. This grant happens to be one of the largest federal grants ever received by Trinity Health, the parent organization to St. Joseph Mercy Health.

St. Joseph Mercy Health System

St. Joseph Mercy Health System, part of Trinity Health, is one of the largest health care networks based in southeast Michigan. It consists of five hospitals, nine urgent care cents, and five health centers distributed around metro Detroit and six counties including Livingston, Macomb, Oakland, St. Clair, Washtenaw, and Wayne.

Trinity Health

Trinity Health is an American not-for-profit Catholic health system operating 93 hospitals in 22 states, including 120 continuing care locations encompassing home care, hospice, PACE and senior living facilities. Based in Livonia Michigan, Trinity employs over 120,000 people including 5,300 physicians. Sponsored by Catholic Health Ministries, Trinity Health operates facilities in many U.S. states.

The Grant: Dr. Philip Stella Emerges as Top Funded Clinical Investigator in Michigan

The $19.3 million grant is one of the largest that Trinity Health, St. Joseph Mercy Health’s parent organization, every received and places Dr. Philip Stella, the principal investigator, as one of the top funded cancer researchers in the State of Michigan. Now patients throughout the 13-hospital consortium, spanning three states, can participate in leading-edge clinical trials offering access to the most advanced cancer treatments available in the nation.

A National Leader in Personalized Medicine for Cancer Research

St. Joseph Mercy Health hails itself as a national leader in personalized medicine with clinical trials that use advanced targeted agents based on the genomics of the patient’s tumor as well as the latest immunotherapy clinical trials.

Additionally, their Community Oncology Research Program actively participates in assessing the latest surgical and radiation techniques and methods to reduce the side effects of cancer treatments.

St. Joseph has other Michigan-based medical facilities participating, including those in Ann Arbor, Canton, Chelsea, Oakland, and Livonia.

Lead Research/Investigator

Dr. Philip Stella, the principal investigator

Call to Action: If you or a loved one has a diagnosed cancer and are in a treatment area for St. Joseph Mercy Health System, we recommend considering research into the various clinical trials options, not to mention their clinical investigators, such as Dr. Stella, for a second option if needed. Dr. Stella’s contact: http://www.stjoeshealth.org/body.cfm?id=6863&action=detail&ref=16883&fr=true. For sponsors interested in partnering with the health system for oncology research, we offer a link to some of their experts for review.

0 Comments

Pin It on Pinterest